Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varlitinib and Paclitaxel in EGFR/HER2+ Gastric Cancer
NCT05400915Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Jul 2019
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
A Phase 2 trial of varlitinib in gastric cancer (GC), sponsored by Yonsei University. Started Jul 2019; status: completed.
02
Drugs
varlitinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05400915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05400915.